ArticleInternational journal of cancer2026

Enfortumab vedotin plus pembrolizumab in treatment-naïve metastatic urothelial carcinoma patients: An Austrian real-world analysis.

Dora Niedersuess-Beke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.